Literature DB >> 20231909

Testing for associations with missing high-dimensional categorical covariates.

Jennifer Schumi1, A Gregory DiRienzo, Victor DeGruttola.   

Abstract

Understanding how long-term clinical outcomes relate to short-term response to therapy is an important topic of research with a variety of applications. In HIV, early measures of viral RNA levels are known to be a strong prognostic indicator of future viral load response. However, mutations observed in the high-dimensional viral genotype at an early time point may change this prognosis. Unfortunately, some subjects may not have a viral genetic sequence measured at the early time point, and the sequence may be missing for reasons related to the outcome. Complete-case analyses of missing data are generally biased when the assumption that data are missing completely at random is not met, and methods incorporating multiple imputation may not be well-suited for the analysis of high-dimensional data. We propose a semiparametric multiple testing approach to the problem of identifying associations between potentially missing high-dimensional covariates and response. Following the recent exposition by Tsiatis, unbiased nonparametric summary statistics are constructed by inversely weighting the complete cases according to the conditional probability of being observed, given data that is observed for each subject. Resulting summary statistics will be unbiased under the assumption of missing at random. We illustrate our approach through an application to data from a recent AIDS clinical trial, and demonstrate finite sample properties with simulations.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 20231909      PMCID: PMC2835453          DOI: 10.2202/1557-4679.1102

Source DB:  PubMed          Journal:  Int J Biostat        ISSN: 1557-4679            Impact factor:   0.968


  7 in total

1.  Augmentation procedures for control of the generalized family-wise error rate and tail probabilities for the proportion of false positives.

Authors:  Mark J van der Laan; Sandrine Dudoit; Katherine S Pollard
Journal:  Stat Appl Genet Mol Biol       Date:  2004-06-15

2.  Multiple testing. Part II. Step-down procedures for control of the family-wise error rate.

Authors:  Mark J van der Laan; Sandrine Dudoit; Katherine S Pollard
Journal:  Stat Appl Genet Mol Biol       Date:  2004-06-14

3.  Empirical Bayes and resampling based multiple testing procedure controlling tail probability of the proportion of false positives.

Authors:  Mark J van der Laan; Merrill D Birkner; Alan E Hubbard
Journal:  Stat Appl Genet Mol Biol       Date:  2005-10-07

4.  Multiple testing. Part I. Single-step procedures for control of general type I error rates.

Authors:  Sandrine Dudoit; Mark J van der Laan; Katherine S Pollard
Journal:  Stat Appl Genet Mol Biol       Date:  2004-06-09

5.  Resampling-based analyses of the effects of combinations of HIV genetic mutations on drug susceptibility.

Authors:  Jennifer Schumi; Victor Degruttola
Journal:  Stat Med       Date:  2008-10-15       Impact factor: 2.373

6.  Patterns of plasma human immunodeficiency virus type 1 RNA response to antiretroviral therapy.

Authors:  W Huang; V De Gruttola; M Fischl; S Hammer; D Richman; D Havlir; R Gulick; K Squires; J Mellors
Journal:  J Infect Dis       Date:  2001-04-24       Impact factor: 5.226

7.  Dual vs single protease inhibitor therapy following antiretroviral treatment failure: a randomized trial.

Authors:  Scott M Hammer; Florin Vaida; Kara K Bennett; Mary K Holohan; Lewis Sheiner; Joseph J Eron; Lawrence Joseph Wheat; Ronald T Mitsuyasu; Roy M Gulick; Fred T Valentine; Judith A Aberg; Michael D Rogers; Cheryl N Karol; Alfred J Saah; Ronald H Lewis; Laura J Bessen; Carol Brosgart; Victor DeGruttola; John W Mellors
Journal:  JAMA       Date:  2002-07-10       Impact factor: 56.272

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.